NanoHLA: A Method for Human Leukocyte Antigen Class I Genes Typing Without Error Correction Based on Nanopore...

Area of Science:

• Genomics
• Bioinformatics
• Immunogenetics

Background:

• Human leukocyte antigen (HLA) typing is crucial for transplantation, disease diagnosis, and forensics.
• Nanopore sequencing offers rapid and cost-effective HLA typing but lacks robust bioinformatics tools.
• Analyzing thousands of HLA alleles from nanopore data presents a significant bioinformatics challenge.

Purpose of the Study:

• To develop a robust and generalizable bioinformatics tool for high-resolution HLA class I typing using nanopore sequencing data.
• To address the scarcity of effective tools for analyzing nanopore-based HLA sequencing data.
• To enable accurate deciphering of numerous HLA alleles.

Main Methods:

• Developed NanoHLA, a tool for HLA class I gene typing without error correction.
• Integrated HLA type coverage analysis and data conversion techniques (similar to Nano2NGS).
• Applied nanopore sequencing data to Next-Generation Sequencing (NGS)-like analysis pipelines.

Main Results:

• NanoHLA achieved an 84.34% concordance rate for HLA-A, HLA-B, and HLA-C on public nanopore datasets.
• Demonstrated superior performance compared to existing tools like HLA-LA.
• Provided a validated method for high-resolution HLA typing from nanopore data.

Conclusions:

• NanoHLA offers a valuable tool for high-resolution HLA typing using nanopore sequencing.
• The tool addresses key challenges in analyzing nanopore-based HLA data.
• NanoHLA is expected to advance the application of nanopore sequencing in research and clinical settings.